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The British government’s efforts to
study the potential impact of the
disease linked to bovine spongiform
encephalopathy (BSE), now
confirmed in more than 100 people,
hit a setback last month when
scientists studying sheep brains for
evidence of BSE found that they
were, in fact, working on material
entirely derived from cows. The mix-
up deepens uncertainty about the
potential number of Britons infected
with the novel brain condition,
variant Creutzfeldt–Jacob disease
(vCJD) linked to BSE, and fuels bans
on the donation of blood from British
donors outside the UK.
The British government was first
told early in the summer that sheep
brain material they were testing for
BSE appeared to contain traces of
bovine remains. The study followed
fears that sheep, as well as cows,
may have been infected with BSE.
The government ordered DNA tests
on the experiment, which revealed
last month that the five-year project
had been ruined. “We had known
for a while that the experiment had
been undermined by contamination
issues,” a department of rural affairs
official said. “But we thought that
just part of the experiment had been
affected, rather than the whole
thing. We did not know the extent
of it.”
The aim of the experiments was
to see if there was any evidence of
BSE in sheep from the early 1990s to
help develop a baseline for possible
human exposure. An inquiry is now
under way t o examine the cause of
the mix-up. The government says
that it is unlikely the experiment will
be repeated, as it is now more
important to check the existing
sheep flock rather than old samples.
The latest tests on small numbers of
these animals, carried out by the
Veterinary Laboratories Agency in
Weybridge, found no evidence of
BSE. 
However, all the uncertainties
surrounding vCJD have prompted
the US, Japan, Canada, New
Zealand, Australia and Hong Kong
to refuse blood donations from
anyone who has spent a total of six
months in the UK between 1980
and 1996. Recently, France,
Belgium, Austria, Switzerland and
Spain have also decided to ban
British blood donors.
We thought that just part of the
experiment had been affected,
rather than the whole thing. We
did not the know the extent of it
There is no known case of vCJD
been passed on through blood
transfusions. But governments do not
want to risk the kind of outcry that
arose in France a few years ago when
ministers were accused of causing the
deaths of more than 300 patients who
had received blood contaminated
with HIV.
The race is now on to develop a
simple test for infection that can be
performed on live humans. In July,
Serono Biotech, a pharmaceutical
company based in Geneva,
announced that it could quite soon
have  a suitable test on the market.
The previous month Serono
researchers published in Nature a
method for speeding up prion
replication. Infectious prions
multiply slowly converting normal
healthy protein molecules into new
prions. In infected patients, this goes
on for years but the Serono team
found they could greatly speed up
this process by exposing the samples
to ultrasound.
The company is confident they
can quickly develop a test but many
others think it will be a much longer
haul. Any test would need
particularly exhaustive trials to
determine its accuracy because of the
considerable consequences of giving
a false positive result for a condition
which is fatal and presently
untreatable. And even if a test was
developed the case for routinely
testing blood remains to be
established.
Classic CJD is considered
unlikely to be transmitted through
blood transfusion as only the tissues
of the central nervous system are
infectious. The same is true of BSE
in cattle and scrapie in sheep.
However, there is good reason to
believe that vCJD is not restricted 
in the same way. Infectious prions
have been found in the tonsils and
spleens of several cases of vCJD
indicating that, in humans, the
disease is no longer confined to the
nervous system. It was because of
these findings that fears were first
raised over the possible infectivity 
of blood, particularly white 
blood cells.
The latest setback with the sheep
studies suggests that the ban on
British blood donations abroad and
continuing uncertainty at home are
likely to continue for some
considerable time.
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